A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

计划入组 100 人 · 首次发布于 2023 年 5 月 17 日

Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

计划入组 60 人 · 首次发布于 2016 年 5 月 5 日

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

计划入组 1,000 人 · 首次发布于 2018 年 12 月 7 日

Cyclohexanediol(F. Hoffmann-La Roche Ltd.)

RO-51-32822(F. Hoffmann-La Roche Ltd.)

Malaria DNA vaccine(F. Hoffmann-La Roche Ltd.)

F. Hoffmann-La Roche Ltd

United States

F. Hoffmann-La Roche Ltd.

Switzerland

F. Hoffmann-La Roche AG

Switzerland

Lixte Biotechnology and Netherlands Cancer Institute Partner to Trial LB-100 in Metastatic Colon Cancer

Lixte Biotechnology Receives Nasdaq Extension and Advances LB-100 Clinical Trial

Lixte Biotechnology Faces Nasdaq Delisting Over Equity Shortfall, Plans Compliance Measures